Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Alimentary Pharmacology & Therapeutics|July 5, 2006
Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancerS Lecleire, F Di Fiore, E Ben-Soussan, et al.
Bulletin Du Cancer|March 1, 1993
[Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers]T Conroy, J Wils, B Paillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancerE J Roelofs, D J Wagener, T Conroy, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1989
Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trialA Roussel, H Bleiberg, O Dalesio, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-GITCCG (European Organization for Research and Treatment of Cancer, Gastrointestinal Tract Cancer Cooperative Group)P Rougier, C van Pottelsberghe, T Kok, et al.
Gastroenterologie Clinique Et Biologique|April 12, 2003
[Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)]J F Seitz, C Milan, M Giovannini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancerF Bonnetain, O Bouché, P Michel, et al.
Cancer Research|December 15, 1996
Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancerJ L Mauillon, P Michel, J M Limacher, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancerH Bleiberg, T Conroy, B Paillot, et al.
British Journal of Cancer|January 13, 2006
'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'J Bennouna, H Perrier, B Paillot, et al.
Pageof 4